Literature DB >> 6423434

Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer.

M Deleers, W J Malaisse.   

Abstract

Hypoglycaemic sulphonylureas bind to multilamellar liposomes formed of egg yolk phosphatidylcholine. In this artificial model, both specific and non-specific components of the binding phenomenon can be characterized by the same criteria as those used in studies performed with natural membranes. The relative ability of distinct sulphonylureas to inhibit the binding of 3H-glibenclamide or 3H-gliquidone to the liposomes parallels their relative potency as insulin secretagogues. It is proposed that the insertion of hypoglycaemic sulphonylureas into the phospholipid domain of the B cell membrane could represent a primary event in the mechanism by which these agents stimulate insulin release.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423434     DOI: 10.1007/bf00252264

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  [Comparative use of gliquidone and tolbutamide administered intravenously].

Authors:  T Zilker; L Lüders; P Bottermann
Journal:  MMW Munch Med Wochenschr       Date:  1975-09-05

2.  The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

Authors:  B Hellman; J Sehlin; I B Täljedal
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

3.  Ionophore-mediated calcium exchange diffusion in liposomes.

Authors:  M Deleers; W J Malaisse
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

4.  Ionic determinants of bioelectrical spiking activity in the pancreatic B-cell.

Authors:  W J Malaisse; P Lebrun; A Herchuelz
Journal:  Pflugers Arch       Date:  1982-11-11       Impact factor: 3.657

Review 5.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

6.  Uptake of glibornuride by microdissected pancreatic islets.

Authors:  I B Täljedal
Journal:  Horm Res       Date:  1974

7.  Insulinotropic action of a new sulfonylurea: gliclazide.

Authors:  W J Malaisse; V Leclercq-Meyer
Journal:  Rev Eur Etud Clin Biol       Date:  1972-03

8.  Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.

Authors:  J C Henquin; H P Meissner
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

9.  Changes in membrane lipids of the beta-cell during insulin secretion.

Authors:  W Montague; E N Parkin
Journal:  Horm Metab Res Suppl       Date:  1980

10.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Authors:  F Szoka; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

View more
  10 in total

1.  Fate of 3H- and 14C-labelled A-4166 in pancreatic islets.

Authors:  F Malaisse-Lagae; W J Malaisse
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  Internalization of 3H-glibenclamide in pancreatic islet cells.

Authors:  J L Carpentier; F Sawano; M Ravazzola; W J Malaisse
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

3.  Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.

Authors:  B J Zünkler; S Lenzen; K Männer; U Panten; G Trube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

Review 4.  Interaction of sulfonylurea with the pancreatic B-cell.

Authors:  E Gylfe; B Hellman; J Sehlin; B Täljedal
Journal:  Experientia       Date:  1984-10-15

5.  Uptake of tritiated glibenclamide by endocrine and exocrine pancreas.

Authors:  L Ladrière; F Malaisse-Lagae; W J Malaisse
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

6.  Uptake of tritiated glibenclamide by endocrine and exocrine pancreas.

Authors:  L Ladrière; F Malaisse-Lagae; W J Malaisse
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

7.  Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.

Authors:  M Schwanstecher; C Brandt; S Behrends; U Schaupp; U Panten
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

9.  Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.

Authors:  A Sener; A G Akkan; W J Malaisse
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

10.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.

Authors:  G Trube; P Rorsman; T Ohno-Shosaku
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.